Survey: Strategic Partnerships Perceived As Most Effective Outsourcing Model

By Ed Miseta, Chief Editor, Clinical Leader

A report issued by PAREXEL has revealed that strategic partnerships are the most effective biopharmaceutical outsourcing model when it comes to meeting key sponsor needs. The report, titled Strategic Partnerships 2014: Driving Biopharmaceutical Outsourcing Effectiveness, was released at the 23^rd annual Partnerships in Clinical Trials Conference.

The goal of the report was to provide insights and highlights into the value of multi-year, highly-integrated engagements between sponsors and CROs. The data contained in the report is the result of an online survey of 148 senior-level executives representing large, mid-sized, and small biopharmaceutical companies. The survey, conducted by Blue Pyramid Consulting, a subsidiary of the Avoca Group, included both quantitative and qualitative questions, as well as single- and multiple-response questions.

The report also shows among the companies surveyed, more than half currently use a strategic partnership model. This was the preferred model of 54% of firms in the U.S., 50% of firms in Europe, and 53% of firms in Asia. Additionally, the report finds positive perceptions of outsourcing effectiveness within the biopharmaceutical industry have increased significantly over the last three years across all geographies as well as companies of all sizes.